FIFPro statement: Player health in Cyprus

Press Release

29th November 2018

FIFPro is calling for an urgent inquiry into medical treatment administered to players under the care of at least four first-division football clubs in Cyprus.

FIFPro understands players at these clubs have had unidentified substances administered, some of them intravenously, to aid their physical recovery. Three of these players have been diagnosed recently with a serious heart condition.

The world player union has written to the Cyprus Football Association, the Cyprus Sports Organization and UEFA expressing concern and asking for their immediate assistance.

Because of concerns there is a link between the unidentified substances and the serious heart condition of the three players, FIFPro is calling for football authorities to help identify what was administered to them and to establish if their teammates are in danger.

The substances are understood to have been administered since the start of the 2017/18 season. Some of the players under the care of the four football clubs last season have since left Cyprus to continue their careers elsewhere.

FIFPro and the Cyprus player union (PASP) are providing medical and financial support to the three footballers diagnosed with a serious heart condition.

Views

475

Leave a comment

Please login to leave a comment.

Official partners 

BASL
Soccerex Core Logo
SLA LOGO 1kpx
YRDA Logo2
SAC logo LawAccord

Copyright © LawInSport Limited 2010 - 2018. These pages contain general information only. Nothing in these pages constitutes legal advice. You should consult a suitably qualified lawyer on any specific legal problem or matter. The information provided here was accurate as of the day it was posted; however, the law may have changed since that date. This information is not intended to be, and should not be used as, a substitute for taking legal advice in any specific situation. LawInSport is not responsible for any actions taken or not taken on the basis of this information. Please refer to the full terms and conditions on our website.